Novel angiogenesis inhibitors: Addressing the issue of redundancy in the angiogenic signaling pathway

This publication has 112 references indexed in Scilit:

• Sorafenib in Advanced Hepatocellular Carcinoma
  New England Journal of Medicine, 2008
• Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
  New England Journal of Medicine, 2007
• VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade
  Proceedings of the National Academy of Sciences, 2007
• Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
  New England Journal of Medicine, 2007
• AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
  Cancer Cell, 2007
• Angiogenesis in life, disease and medicine
  Nature, 2005
• Molecular regulation of vessel maturation
  Nature Medicine, 2003
• The biology of VEGF and its receptors
  Nature Medicine, 2003
• Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
  Cell, 1996
• What Is the Evidence That Tumors Are Angiogenesis Dependent?
  JNCI: Journal of the National Cancer Institute, 1990